Danco Mifeprex adverse events
Revised 1labeling for Danco's abortifacient Mifeprex (mifepristone/RU-486) expands list of potential adverse reactions to include allergic reaction, hypotension, light-headedness, loss of consciousness, post-abortal infection, ruptured ectopic pregnancy, shortness of breath and tachycardia. Reports of infections, ruptured ectopic pregnancies and bleeding prompted FDA to strengthen Mifeprex' "black box" warning in November (2"The Pink Sheet" Nov. 22, 2004, p. 8)...
You may also be interested in...
FDA's decision to strengthen warnings on Danco's Mifeprex (mifepristone) is not a signal that the agency will move to pull the product off the market, Center for Drug Evaluation & Research Acting Director Steven Galson, MD, said Nov. 16
Japan approves a batch of new products and indications, including Daiichi Sankyo's Enhertu in a high-need indication after a rapid review and Takeda's Zejula, which will be made available to selected patients before its reimbursement listing.
Public Company Edition: Outside the US, Zai Lab raised more in its recent Hong Kong initial public offering – $766.4m – than PMV, Prelude, Taysha, Graybug and Greenwich combined. Also, Gilead priced debt to fund its $21bn Immunomedics buy and ADC Therapeutics raised $204m.